Therapeutic Asset Ratings
19,639 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cyclophosphamide
Head And Neck Carcinoma
National Cancer Institute (NCI)
P2
BB
(70)
Cyclophosphamide
Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
Beijing Biotech
P2
BB
(70)
Cyclophosphamide
Mycosis Fungoides/Sezary Syndrome
University of Michigan Rogel Cancer Center
P2
BB
(70)
Cyclophosphamide
Oropharyngeal Carcinoma
HRYZ Biotech Co.
P2
BB
(70)
Cyclophosphamide
Ovarian Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(70)
Cyclophosphamide
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Cyclophosphamide
Hairy Cell Leukemia
Kite, A Gilead Company
P2
BB
(70)
Cytosin-Arabinosid
Acute Biphenotypic Leukemia
University of Washington
P2
BB
(70)
Cytosin-Arabinosid
Follicular Lymphoma
Genmab
P2
BB
(70)
DEXAMETHASONE
Post-transplant Lymphoproliferative Disorder
Northwestern University
P2
BB
(70)
Durvalumab
Ovarian Carcinoma
AGO Research GmbH
P2
BB
(70)
Durvalumab
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P2
BB
(70)
ETOPOSIDE
Nodal Marginal Zone B-Cell Lymphoma
University of California, Davis
P2
BB
(70)
FILGRASTIM
Acute Biphenotypic Leukemia
Ossium Health, Inc.
P2
BB
(70)
FILGRASTIM
Precancerous Condition
City of Hope Medical Center
P2
BB
(70)
Fludarabine
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Fludarabine
Angioimmunoblastic T-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Fludarabine
B-cell Adult Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
P2
BB
(70)
Fludarabine
MALT Lymphoma
UNC Lineberger Comprehensive Cancer Center
P2
BB
(70)
Fludarabine
Nodal Marginal Zone B-Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
P2
BB
(70)
Golcadomide
Diffuse Large B-Cell Lymphoma
Fondazione Italiana Linfomi - ETS
P2
BB
(70)
Ibrutinib
Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
CD20 Positive
M.D. Anderson Cancer Center
P2
BB
(70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
T-Cell Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P2
BB
(70)
Showing 201 to 225 of 19,639 assets
Previous
Page 9 of 786
Next